The Technical Analyst
Medicine Man [SHWZ]
Exchange: PNK Industry: Consulting Services
Medicine Man Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.02% $0.620
America/New_York / 3 mai 2024 @ 15:14
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 48.02 mill |
| EPS: | -0.660 |
| P/E: | -0.940 |
| Earnings Date: | May 15, 2024 |
| SharesOutstanding: | 77.44 mill |
| Avg Daily Volume: | 0.0682 mill |
| RATING 2024-05-03 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.940 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.940 | industry: PE -2.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.513 - 0.727 ( +/- 17.26%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-11 | Pabon Daniel | Buy | 150 | Common Stock |
| 2024-03-29 | Dye Justin | Buy | 91 463 | Common Stock |
| 2024-03-29 | Stewart Brad | Buy | 34 451 | Common Stock |
| 2024-03-29 | Montalbano Paul Joseph | Buy | 32 012 | Common Stock |
| 2024-03-29 | Berger Jonathan W | Buy | 66 159 | Common Stock |
| INSIDER POWER |
|---|
| 4.97 |
| Last 97 transactions |
| Buy: 6 376 754 | Sell: 10 378 003 |
Forecast:
16:00 - $0.620
Live Trading Signals (every 1 min)
Forecast
1: 15:24 - $0.624
Forecast 2: 16:00 - $0.620
Forecast 3: 16:00 - $0.620
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.620 (0.02% ) |
| Volume | 0.0176 mill |
| Avg. Vol. | 0.0682 mill |
| % of Avg. Vol | 25.77 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SHWZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SHWZ
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
Latest Press Releases
2024-04-29 16:30:00 - Press Release
Schwazze Sets First Quarter 2024 Conference Call For May 15, 2024 At 5:00 P.m. Et
Denver , april 29, 2024 /prnewswire/ - medicine man technologies, inc., operating as schwazze, (otcqx: shwz) (cboe ca: shwz) ("schwazze" or the "company"), will host a conference call on wednesday, may 15, 2024 at 5:00 p.m. eastern time to discuss its financial and operational results for the first quarter ended march 31, 2024.
2024-03-27 16:05:00 - Press Release
Schwazze Announces Fourth Quarter And Full Year 2023 Financial Results
Fy 2023 revenue of $172.4 million; income from operations of $3.3 million; adjusted ebitda of $53.4 million or 31% of revenue generated $12.2 million of operating cash flow in fy 2023 denver , march 27, 2024 /prnewswire/ - medicine man technologies, inc., operating as schwazze, (otcqx: shwz) (cboe: shwz) ("schwazze" or the "company"), today announced financial and operational results for the fourth quarter and full year ended december 31, 2023. "this past year, the schwazze team delivered solid top-line growth in two highly competitive markets with 31% adjusted ebitda margins and improved operating cash flow," said forrest hoffmaster, interim ceo of schwazze.
2024-03-12 16:30:00 - Press Release
Schwazze Sets Fourth Quarter And Full Year 2023 Conference Call For March 27, 2024 At 5:00 P.m. Et
Denver , march 12, 2024 /prnewswire/ - medicine man technologies, inc., operating as schwazze, (otcqx: shwz) (cboe: shwz) ("schwazze" or the "company"), will host a conference call on wednesday, march 27, 2024 at 5:00 p.m. eastern time to discuss its financial and operational results for the fourth quarter and full year ended december 31, 2023.
2024-02-23 07:30:00 - Press Release
Schwazze Appoints Forrest Hoffmaster As Interim Chief Executive Officer
Denver, feb. 23, 2024 /prnewswire/ - medicine man technologies, inc., operating as schwazze, (otcqx: shwz) (neo: shwz) ("schwazze" or the "company"), today announced that forrest hoffmaster, the company's chief financial officer, has been appointed to the additional role of interim chief executive officer ("ceo"). this follows nirup krishnamurthy's resignation as ceo and as a member of the board of directors ("board"), effective february 20, 2024, due to personal reasons.
2023-11-14 16:05:00 - Press Release
Schwazze Announces Third Quarter 2023 Financial Results
Q3 revenue of $46.7 million; income from operations of $8.9 million; adjusted ebitda of $14.1 million or 30% of revenue generated $6.9 million of operating cash flow denver , nov. 14, 2023 /prnewswire/ - medicine man technologies, inc., operating as schwazze, (otcqx: shwz) (neo: shwz) ("schwazze" or the "company"), today announced financial and operational results for the third quarter ended september 30, 2023. third quarter 2023 summary for the three months ended $ in thousands usd september 30,2023 june 30,2023 september 30, 2022 total revenue $46,747 $42,375 $43,191 gross profit $21,438 $24,519 $22,476 operating expenses $12,514 $19,562 $11,361 income from operations $8,924 $4,957 $11,115 adjusted ebitda[1] $14,119 $13,814 $15,860 operating cash flow $6,946 $2,683 $10,298 management commentary "we continued to increase our retail footprint during the quarter to a total of 63 stores in colorado and new mexico, while further integrating our recently-acquired assets in both states," said nirup krishnamurthy, ceo of schwazze.
Latest News
2024-04-29 16:30:00 - PRNewsWire
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
DENVER , April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024.
2024-03-27 21:22:42 - Seeking Alpha
Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript
2024-03-12 16:30:00 - PRNewsWire
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
DENVER , March 12, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023.
2024-03-10 12:03:54 - MarijuanaStocks
From Seed to Profit: The Top Cannabis Penny Stocks to Watch
Diving into the dynamic world of U.S. marijuana stocks offers a glimpse into a sector pulsing with growth and brimming with investment prospects. This burgeoning market has captured investors' attention, especially those eyeing the high-risk, high-reward landscape of marijuana penny stocks. Companies such as Jushi Holdings Inc., Acreage Holdings, Inc., and Medicine Man Technologies, Inc. (now under Schwazze) stand out. They're not just surviving; they're thriving, expanding their footprints, and strategically navigating the complexities of a market at the cusp of nationwide acceptance. With each legislative nod towards legalization, whether for medicinal or recreational use, these companies inch closer to unlocking their full potential, making them ones to watch in the ever-greening landscape of cannabis investment.
2023-11-14 19:28:08 - Seeking Alpha
Medicine Man Technologies, Inc. (SHWZ) Q3 2023 Earnings Call Transcript
Medicine Man Technologies, Inc. (OTCQX:SHWZ) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Sean Mansouri - Elevate IR Nirup Krishnamurthy - CEO Forrest Hoffmaster - CFO Justin Dye - Chairman Conference Call Participants Operator My name is Lester, and I will be your conference operator today. At this time, I would like to welcome everyone to Schwazze Third Quarter 2023 Conference Call.
2023-08-29 14:00:37 - MarijuanaStocks
Marijuana Penny Stocks for September Investment Watchlist
As the cannabis industry grows rapidly, investors are looking for top marijuana penny stocks set for growth. With September fast coming, these possible jewels deserve special attention. The industry's expected expansion, supported by solid facts, fuels hope for significant rewards.
2023-08-17 09:42:51 - InvestorPlace
7 Smoking-Hot 420 Stocks to Buy in 2023
Sentiment for the cannabis sector has yet to rebound from its last peak in late 2020/early 2021, but that doesn't mean you need to skip out on 420 stocks. Even Forbes recently argued that full U.S. legalization of marijuana remains (at least) a decade away.
2023-07-07 13:00:08 - MarijuanaStocks
3 Top Marijuana Stocks To Watch This Week
Marijuana stock investors are keeping watch for the next investment opportunity. With the current wave of volatile trading, the end result every investor wants to see is a rise in trading. Yet this volatile action has impacted the cannabis sector for some time now. This has left many shareholders in a place where they need to be quick enough to take profits when there is a bounce. But when there is a recovery most times companies have not been able to sustain that momentum.
2023-05-11 07:00:40 - MarijuanaStocks
3 Marijuana Stocks To Buy Today To Make Some Money?
Top Marijuana Stocks For Your May Portfolio The post 3 Marijuana Stocks To Buy Today To Make Some Money? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
2023-05-11 03:36:09 - Seeking Alpha
Medicine Man Technologies, Inc. (SHWZ) Q1 2023 Earnings Call Transcript
Medicine Man Technologies, Inc. (OTCQX:SHWZ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Joanne Jobin - Investor Relations Justin Dye - Chairman and Chief Executive Officer Nirup Krishnamurthy - President Forrest Hoffmaster - Chief Financial Officer Operator Good afternoon. My name is Jenny and I will be your conference operator today.